News
Managing acute pain in inpatients on OUD therapy
August 21, 2020
“This is something we’re going to see more frequently, and many of us already have.”
News
NBA star Mason Plumlee on COVID and life inside the Orlando ‘bubble’
August 21, 2020
Each week we interview key opinion leaders involved in various aspects of blood and cancer. In this episode we have a different kind of key opinion leader, our guest is NBA star Mason Plumlee, a forward with the Denver Nuggets.
![1]()
News
Performance status, molecular testing key to metastatic cancer prognosis
August 20, 2020
“The applicability of clinical trials data to hospitalized patients is generally poor. That’s an important caveat to keep in mind.”
![1]()
News
Oleander extract for COVID-19? That’s a hard ‘no’ experts say
August 20, 2020
Oleandrin poisoning may affect the central nervous system, as evidenced by drowsiness, tremors, seizures, collapse, and coma leading to death.
News
Pulmonary rehab reduces COPD readmissions
August 19, 2020
Rehabilitation was associated with a lower risk for readmission.
![1]()
News
PHM20 Virtual: Can’t miss heart disease for hospitalists
August 19, 2020
Congenital heart disease often presents with either cyanosis, hypoperfusion, failure to thrive, or respiratory distress.
![1]()
News
COVID-19 child case count now over 400,000
August 19, 2020
For the first time, the percentage of cases in children did not increase from 1 week to the next.
![1]()
News
HFNC more comfortable for posthypercapnic patients with COPD
August 19, 2020
High-flow nasal cannula appears to be an effective means of respiratory support for COPD patients extubated after severe hypercapnic respiratory failure.
News
Evidence mounts for COVID-19 effects on thyroid gland
August 19, 2020
Among severely ill patients with COVID-19, rates of thyrotoxicosis are significantly higher than among patients without it. But those with thyroid disorders are not at increased risk of contracting SARS-CoV-2.
News
Non-COVID-19 clinical trials grind to a halt during pandemic
August 19, 2020
Many more trials than usual are being paused or stopped, new findings suggest, creating downstream disruption to product availability and issues with data integrity and statistical interpretation.
